Search Results 491-500 of 18846 for crohns disease
Is male or female with Ulcerative Colitis or Crohn's Disease and was between 2 to 17 years, inclusive, at the time of randomization for Study MLN0002-2003.
New medications have improved pediatric IBD care, but surgery is still an important option to cure ulcerative colitis and reduce Crohn's disease symptoms.
The goal of this study is to create a cohort of patients with Inflammatory Bowel Disease (IBD) who have linked clinical data, self-reported outcome data, and ...
... and endoscopic response in participants with moderate to severe Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender ...
Crohn's disease; Diaphragmatic hernia; Embryonal tumors · Familial adenomatous ... Inflammatory bowel disease (IBD) · Inguinal hernia · Intestinal obstruction ...
... Crohn's disease (CD). Also to assess the safety, immunogenicity and efficacy ... Participant eligibility includes age, gender, type and stage of disease, and ...
Mayo Clinic gastroenterologists and hepatologists in Florida offer focused expertise in several specialty areas, such as: Inflammatory Bowel Disease Clinic: ...
The purpose of this study is to evaluate the long-term safety of a single dose of darvadstrocel in participants with Crohn's disease (CD) and complex perianal ...
... Disease: Hidradenitis Suppurativa and Inflammatory Bowel Disease. ... Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol ...
Clinical Trials · A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.